204 related articles for article (PubMed ID: 29915392)
1. O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1.
Phoomak C; Silsirivanit A; Park D; Sawanyawisuth K; Vaeteewoottacharn K; Wongkham C; Lam EW; Pairojkul C; Lebrilla CB; Wongkham S
Oncogene; 2018 Oct; 37(42):5648-5665. PubMed ID: 29915392
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma.
Phoomak C; Park D; Silsirivanit A; Sawanyawisuth K; Vaeteewoottacharn K; Detarya M; Wongkham C; Lebrilla CB; Wongkham S
Mol Oncol; 2019 Feb; 13(2):338-357. PubMed ID: 30444036
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB.
Phoomak C; Vaeteewoottacharn K; Sawanyawisuth K; Seubwai W; Wongkham C; Silsirivanit A; Wongkham S
Sci Rep; 2016 Jun; 6():27853. PubMed ID: 27290989
[TBL] [Abstract][Full Text] [Related]
4. CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion.
Dana P; Saisomboon S; Kariya R; Okada S; Obchoei S; Sawanyawisuth K; Wongkham C; Pairojkul C; Wongkham S; Vaeteewoottacharn K
Cell Oncol (Dordr); 2020 Apr; 43(2):211-222. PubMed ID: 31729681
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity.
Uthaisar K; Vaeteewoottacharn K; Seubwai W; Talabnin C; Sawanyawisuth K; Obchoei S; Kraiklang R; Okada S; Wongkham S
Oncol Rep; 2016 Sep; 36(3):1435-46. PubMed ID: 27461717
[TBL] [Abstract][Full Text] [Related]
6. High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation.
Phoomak C; Vaeteewoottacharn K; Silsirivanit A; Saengboonmee C; Seubwai W; Sawanyawisuth K; Wongkham C; Wongkham S
Sci Rep; 2017 Mar; 7():43842. PubMed ID: 28262738
[TBL] [Abstract][Full Text] [Related]
7. The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling.
Detarya M; Sawanyawisuth K; Aphivatanasiri C; Chuangchaiya S; Saranaruk P; Sukprasert L; Silsirivanit A; Araki N; Wongkham S; Wongkham C
Glycobiology; 2020 Apr; 30(5):312-324. PubMed ID: 31868214
[TBL] [Abstract][Full Text] [Related]
8. Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells.
Saentaweesuk W; Araki N; Vaeteewoottacharn K; Silsirivanit A; Seubwai W; Talabnin C; Muisuk K; Sripa B; Wongkham S; Okada S; Wongkham C
Oncol Res; 2018 May; 26(4):605-616. PubMed ID: 28762325
[TBL] [Abstract][Full Text] [Related]
9. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.
Yothaisong S; Dokduang H; Techasen A; Namwat N; Yongvanit P; Bhudhisawasdi V; Puapairoj A; Riggins GJ; Loilome W
Tumour Biol; 2013 Dec; 34(6):3637-48. PubMed ID: 23832540
[TBL] [Abstract][Full Text] [Related]
10. Role of Wisteria floribunda agglutinin binding glycans in carcinogenesis and metastasis of cholangiocarcinoma.
Phuyathip W; Putthisen S; Panawan O; Ma-In P; Teeravirote K; Sintusen P; Udomkitkosol S; Detarya M; Luang S; Mahalapbutr P; Sato T; Kuno A; Chuangchaiya S; Silsirivanit A
Histochem Cell Biol; 2024 May; 161(5):423-434. PubMed ID: 38393396
[TBL] [Abstract][Full Text] [Related]
11. Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma.
Poosekeaw P; Pairojkul C; Sripa B; Sa Ngiamwibool P; Iamsaard S; Sakonsinsiri C; Thanan R; Ungarreevittaya P
PLoS One; 2021; 16(11):e0259075. PubMed ID: 34780466
[TBL] [Abstract][Full Text] [Related]
12. Comparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of Invasion.
Wasuworawong K; Roytrakul S; Paemanee A; Jindapornprasert K; Komyod W
Dis Markers; 2015; 2015():629367. PubMed ID: 25999659
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of O-GlcNAc-transferase associates with aggressiveness of mass-forming cholangiocarcinoma.
Phoomak C; Silsirivanit A; Wongkham C; Sripa B; Puapairoj A; Wongkham S
Asian Pac J Cancer Prev; 2012; 13 Suppl():101-5. PubMed ID: 23480751
[TBL] [Abstract][Full Text] [Related]
14. An aberrantly spliced isoform of anterior gradient-2, AGR2vH promotes migration and invasion of cholangiocarcinoma cell.
Yosudjai J; Inpad C; Chomwong S; Dana P; Sawanyawisuth K; Phimsen S; Wongkham S; Jirawatnotai S; Kaewkong W
Biomed Pharmacother; 2018 Nov; 107():109-116. PubMed ID: 30086457
[TBL] [Abstract][Full Text] [Related]
15. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S
Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332
[TBL] [Abstract][Full Text] [Related]
16. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
[TBL] [Abstract][Full Text] [Related]
17. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.
Armartmuntree N; Murata M; Techasen A; Yongvanit P; Loilome W; Namwat N; Pairojkul C; Sakonsinsiri C; Pinlaor S; Thanan R
Redox Biol; 2018 Apr; 14():637-644. PubMed ID: 29169115
[TBL] [Abstract][Full Text] [Related]
18. Differential Expression of O-glycoprotein Glycans in Cholangiocarcinoma Cell Lines.
Talabnin K; Talabnin C; Ishihara M; Azadi P; Wongkham S; Sripa B
Asian Pac J Cancer Prev; 2016; 17(2):691-5. PubMed ID: 26925665
[TBL] [Abstract][Full Text] [Related]
19. The Importance of CYP19A1 in Estrogen Receptor-Positive Cholangiocarcinoma.
Kaewlert W; Sakonsinsiri C; Namwat N; Sawanyawisuth K; Ungarreevittaya P; Khuntikeo N; Armartmuntree N; Thanan R
Horm Cancer; 2018 Dec; 9(6):408-419. PubMed ID: 30284180
[TBL] [Abstract][Full Text] [Related]
20. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
